| 标题 |
 667 A phase 1, multiple-dose study to evaluate the safety and tolerability of XmAb®819 (ENPP3 x CD3) in subjects with relapsed or refractory clear cell renal cell carcinoma (RCC) |
| 网址 | |
| DOI |
10.1136/jitc-2022-sitc2022.0667
doi
|
| 其它 |
期刊：Regular and Young Investigator Award Abstracts 作者：Sumanta Pal; Sreeni Yalamanchili; Huajiang Li; Jitendra Kanodia; Raphael Clynes; et al 出版日期：2022-11-08 |
| 求助人 | |
| 下载 | 暂无链接，等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)
Nole
东方元语
张欢馨
cdercder
馆长
xing_xing
Kao
pluto
aajhajkahna
学术文献互助
昏睡的蟠桃
OK
颂歌998
七听
搬砖ing
桑榆
yz
糊涂的灯泡
初景
扎心
皖公网安备34019202002308
